GSA Capital Partners’s Seaport Therapeutics SPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$732K Buy
36,310
+3,132
+9% +$69.6K 0.04% 804
2026
Q2
$721K Buy
+33,178
New +$584K 0.05% 747

Other funds holding SPTX

GSA Capital Partners's SPTX Position: Q3 2026 in Review

GSA Capital Partners increased its Seaport Therapeutics (SPTX) stake by 9.4% in Q3 2026, buying an estimated $69.6K and bringing the position to 36,310 shares worth $732K. The position accounts for 0.04% of the portfolio, ranked #804.

GSA Capital Partners first reported a position in SPTX in Q2 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.

  • GSA Capital Partners held 36,310 shares of Seaport Therapeutics worth $732K as of Q3 2026.
  • GSA Capital Partners bought 3,132 Seaport Therapeutics shares in Q3 2026, an estimated $69.6K.
  • Seaport Therapeutics made up 0.04% of GSA Capital Partners's portfolio in Q3 2026, its #804 holding.
  • GSA Capital Partners first reported a position in Seaport Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.